Israel Corp. Reports Results for Fourth Quarter and Annual 2025
MWN-AI** Summary
Israel Corporation Ltd. (TASE: ILCO) recently released its financial results for the fourth quarter and annual period ending December 31, 2025. The company reported a notable decline in its share of profits, posting a loss of $32 million from its investment in ICL, compared to a $319 million profit in the same period last year. For the full year 2025, ILCO's share in ICL profits totaled $179 million, down from $919 million in 2024.
In terms of net profit to company shareholders, ILCO logged a loss of $37 million in Q4 2025, a significant decrease from a profit of $318 million in Q4 2024. For the total year, the net profit reached $190 million, representing a decline from $719 million in 2024. Key factors contributing to these results include increased amortization costs linked to investments and changes in financial liabilities, which rose to $679 million against liquid asset investments totaling $721 million.
Regarding recent strategic developments, ILCO completed a significant investment agreement with Prodalim Investments Ltd. for approximately $118 million and underwent a dilution of its stake in Prodalim following its successful IPO on February 24, 2026. The company also plans to distribute a dividend of approximately $13 million, scheduled for payment in late April 2026.
As of the end of 2025, ILCO's total assets stood at $3.52 billion, with net cash reported at $73 million. In a notable shift, ILCO will transition to reporting solely in English, reflecting its commitment to enhancing transparency and accessibility for international investors.
MWN-AI** Analysis
Israel Corporation Ltd. (ILCO) has recently reported its fourth-quarter and annual financial results for 2025. The results present a mixed bag, raising considerations for investors regarding future potential.
Notably, ILCO's profit share from its stake in ICL saw a significant downturn in Q4 2025, posting a loss of $32 million compared to a profit of $319 million in Q4 2024. This stark contrast raises red flags about ILCO's reliance on ICL's performance and highlights potential volatility. The net profit attributable to shareholders also swung to a loss of $37 million, a stark decline from $318 million in the prior year. This illustrates a worrying trend in financial health that investors must monitor carefully.
On a positive note, ILCO maintains a robust liquidity position with total financial liabilities of $679 million and investments in liquid assets totaling $721 million. The increase in net cash from $45 million in September 2025 to $73 million by year's end signals improved financial maneuverability. This liquidity could provide a buffer against ongoing uncertainties and support future investments.
The decision to distribute a dividend of approximately $13 million aligns with ILCO's commitment to shareholder returns, although it raises questions about the sustainability of such distributions given the losses in profit.
Moreover, the dilution of ILCO's stake in Prodalim, after its recent IPO, reduces its ownership from about 27.5% to 23.26%, potentially impacting future earnings from this investment.
In conclusion, while ILCO boasts solid liquidity and a commitment to dividend distribution, the significant decline in profits underscores the need for careful scrutiny. Investors should weigh these factors against broader market conditions and the performance of ILCO's key assets to make informed decisions moving forward.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
TEL AVIV, Israel, March 25, 2026 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2025.
Selected Financial Figures for the Fourth Quarter and Annual 2025: | ||||
Q4/25 | Q4/24 | 2025 | 2024 | |
ILCO share in ICL profit | (32) | 31 | 99 | 179 |
ILCO share in Prodalim net profit (loss) | (1) | - | 2 | - |
Amortization of excess cost in held companies | (2) | (1) | (8) | (4) |
Financing, G&A and other at ILCO headquarter level | (3) | 2 | (9) | - |
Tax income (expense) of ILCO headquarters | - | (1) | 3 | 15 |
Net profit to company's shareholders | (37) | 31 | 87 | 190 |
Liquidity at the ILCO Headquarters Level[1]
As of December 31, 2025, total financial liabilities were $679 million, and investments in liquid assets amounted to $721 million.
Net cash[1] as of December 31, 2025, totaled $73 million. The net cash includes the fair value of derivatives transactions, which decreases the economic value of the financial liabilities by $31 million. As of September 30, 2025, the net cash was $45 million.
ILCO Total Assets, Net | |
31/12/2025 | |
Assets | |
ICL (~567m shares, market value) | 3,253 |
Prodalim Investments (cost)[2] | 118 |
AKVA Group (~6.6m shares, market value) | 58 |
Other (market value)[3] | 18 |
Total Assets | 3,447 |
ILCO's Net Cash | 73 |
Total Assets, net | 3,520 |
Recent News
On March 5, 2025, ILCO completed the investment agreement with Prodalim Investments Ltd. ("Prodalim") for a total investment of ~$118m.
On February 24, 2026, Prodalim completed its IPO in the TASE, raising approximately NIS 370 million at a valuation of approximately NIS 2.1 billion. Following the IPO, the Company's holdings in Prodalim were diluted from approximately 27.5% to approximately 23.26% on a fully diluted basis.
On March 25, 2026, ILCO Board of Directors decided on distribution of dividend at the amount of approx. $13m, this in accordance with the company's dividend policy. The record date will be April 14, 2026 and the payment date will be April 27, 2026.
Following a decision of it Board of Directors, ILCO is transitioning to reporting in the English language only[4]. Accordingly, commencing from the date of this report, the Company's periodic and immediate reports will be published in the English language only.
About ILCO
For further information on ILCO, see ILCO's publicly available filings, which can be found on the Tel Aviv Stock Exchange website at http://maya.tase.co.il.
Please also see ILCO company website http://www.israelcorp.com for additional information.
Forward Looking Statements
This press release may contain forward-looking statements, which may not materialize and are subject to risks and uncertainties that are not under the control of ILCO, which may cause actual results to differ materially from those contained in the disclosures.
Investor Relations Contacts
Idan Hizki
Vice President, Business Development
Tel: +972 3 684 4500
idanh@israelcorp.com
[1] Israel Corp and its wholly owned and controlled headquarter companies.
[2] As of February 26, 2026, Prodalim is a public company. As of March 25, 2026, the value of ILCO holdings in Prodalim was ~$155m.
[3] Includes 1.983m shares in Nordic Aqua Partners (OB:NOAP).
[4] For details, including the considerations and reasons for this, see ILCO's report dated November 19, 2025
SOURCE Israel Corporation Ltd.
FAQ**
How did the net profit to the shareholders for Israel Corp. Ltd. IRLCF fluctuate between the fourth quarter of 2025 and the same quarter in 2024, reflecting the challenges or successes faced during that period?
With the recent decrease in ILCO's shareholding in Prodalim from approximately 27.5% to 23.26%, what strategic implications does this dilution have for Israel Corp. Ltd. IRLCF moving forward?
Can you explain the factors that contributed to the negative share in ICL profit for Israel Corp. Ltd. IRLCF in the fourth quarter of 2025, specifically the loss reported compared to the profit in the previous year?
Given the total assets of Israel Corp. Ltd. IRLCF amounting to $3,520 million as of December 31, 2025, how does the company plan to utilize its liquid assets and manage its financial liabilities of $679 million in the upcoming fiscal year?
**MWN-AI FAQ is based on asking OpenAI questions about Israel Corporation Ltd (OTC: IRLCF).
NASDAQ: IRLCF
IRLCF Trading
2485.27% G/L:
$238 Last:
7 Volume:
$238 Open:
